Cetuximab (Erbitux) Clinical Trials
3 recruitingDrug
Phase 23Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer
CRC
Chang Gung Memorial Hospital40 enrolled1 locationNCT07204574
Recruiting
Phase 2
FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis
Colorectal Liver Metastasis (CRLM)
Tongji Hospital300 enrolled1 locationNCT06988852
Recruiting
Phase 2
Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou70 enrolled1 locationNCT06640725